Congenital, End-stage Heart Failure, Heart Failure
Conditions
Keywords
Congenital Heart Failure, Registry, End-stage Heart Failure
Brief summary
Establish a follow-up management system for pediatric heart failure and a registration platform for end-stage heart failure
Interventions
OTHERNo intervention
No intervention
Sponsors
Peking University First Hospital
Beijing Children's Hospital
China National Center for Cardiovascular Diseases
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
No minimum to 14 Years
Healthy volunteers
No
Inclusion criteria
* Patients younger than 14 years of age * refractory heart failure
Exclusion criteria
\-
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| the recurrence rate of heart failure | 6 months | During follow-up visits, echocardiographic examination is conducted to measure the left ventricular function. If LVEF falls under 55%, it is recorded as a recurrence. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| NT-proBNP level | 6 months | The trend in NT-proBNP levels. |
| Incidence rate of drug adverse reactions | 6 months | The incidence of abnormalities in complete blood count, electrolytes, liver and kidney function, and cardiac enzymes. |
| Readmission rate for heart failure | 6 months | During follow-up visits, readmission for heart failure will be recorded. |
Countries
China
Contacts
Primary ContactKai Ma, PhD
Backup ContactZheng Dou, PhD
Outcome results
None listed